Medicament for prevention or treatment of various diseases involving an increase in eosinophils chymase inhibitor as effective ingredient

Details for Australian Patent Application No. 2006201291 (hide)

Owner Daiichi Asubio Pharma Co., Ltd.

Inventors Fukami, Harukazu; Watanabe, Naohiro

Agent Griffith Hack

Pub. Number AU-A-2006201291

Parent 34135

Filing date 28 March 2006

Wipo publication date 27 April 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/536 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems

C07D 239/96 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

13 April 2006 Complete Application Filed

27 April 2006 Application Open to Public Inspection

  Published as AU-A-2006201291

18 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006201292-Medicament for prevention or treatment of fibrosis having chymase inhibitor as effective ingredient

2006201290-Barium and lithium ratio for flux cored electrode